CD133+CD44+CD54+ cellular subpopulation of CTCs has a prognostic value in CRC patients with liver metastasis, especially in the survival of CRC patients with liver metastasis who did not undergo surgical treatment for metastasis. This evidence concerns the gene CD44 and colorectal carcinoma.